Granules India, one of the country’s leading pharmaceutical manufacturing companies has received three observations from US Food and Drug Administration (USFDA) for its Jeedimetla, Hyderabad facility during a recent inspection. USFDA has completed the inspection of company’s two facilities, one located at Vizag in Andhra Pradesh and another at Jeedimetla in Telangana, Granules India. While there were no observations received for Vizag facility, three observations were received for Jeedimetla facility. The company will respond to the observations in 15 business days.
Granules India is a fast growing pharmaceutical company with world-class facilities for APIs, PFIs and Finished Dosages, serving customers in over 60 countries. The company is headquartered in Hyderabad with offices in the U.S., U.K., Colombia and China with manufacturing facilities in India and China.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |